Compare THRY & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | THRY | KRMD |
|---|---|---|
| Founded | 2012 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.3M | 186.5M |
| IPO Year | 2020 | 2019 |
| Metric | THRY | KRMD |
|---|---|---|
| Price | $3.72 | $3.93 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $9.33 | $6.50 |
| AVG Volume (30 Days) | ★ 917.2K | 116.3K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 100.50 | 53.85 |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $785,015,000.00 | $41,127,366.00 |
| Revenue This Year | N/A | $20.32 |
| Revenue Next Year | N/A | $17.37 |
| P/E Ratio | $38.00 | ★ N/A |
| Revenue Growth | N/A | ★ 22.23 |
| 52 Week Low | $1.91 | $2.91 |
| 52 Week High | $14.28 | $6.61 |
| Indicator | THRY | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 51.35 | 45.86 |
| Support Level | $3.46 | $3.82 |
| Resistance Level | $4.17 | $4.33 |
| Average True Range (ATR) | 0.29 | 0.15 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 43.32 | 31.40 |
Thryv Holdings Inc is dedicated to supporting local, independent service-based businesses and emerging franchises by providing a cloud-based software platform, and marketing solutions to entrepreneurs. The group are provider of SaaS all-in-one small business management software in addition to providing print and digital marketing solutions to SMBs. Its solutions enable small and medium-sized business clients to attract and generate new business leads, manage their customer relationships efficiently with artificial intelligence (AI) tools and automation. The group has two business segments; Thryv SaaS deriving maximum revenue and Thryv Marketing Services.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.